Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
J B Chemicals & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:506943NSE Symbol: JBCHEPHARMP/E(TTM):56.68
ISIN Demat:INE572A01036Div & Yield %:0.91EPS(TTM):42.56
Book Value(Rs):251.4786006Market Cap (rupee Cr.):38730.77Face Value(Rs):1
    
(rupee In Cr)
ParticularsMar 2026Dec 2025Sep 2025Jun 2025
 Rs CrRs CrRs CrRs Cr
Gross Sales 836.43990.911022.651039.90
Other Operating Income 0.000.000.000.00
Other Income  10.2416.8914.2513.90
Total Income 846.671007.801036.901053.80
Total Expenditure  668.68721.41724.29746.78
PBIDT 177.99286.39312.61307.02
Interest  1.331.591.010.66
PBDT 176.66284.80311.60306.36
Depreciation 48.5643.6243.1141.40
Tax 36.2758.0864.9963.19
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -4.713.833.083.90
Reported Profit After Tax 96.54179.27200.42197.87
Extra-ordinary Items  -19.480.000.000.00
Adjusted Profit After Extra-ordinary item 116.02179.27200.42197.87
     
EPS (Unit Curr.) 6.0511.4512.8212.70
EPS (Adj) (Unit Curr.) 6.0511.4512.8212.70
Calculated EPS (Unit Curr.) 6.0111.4412.8012.68
Calculated EPS (Adj) (Unit Curr.) 6.0111.4412.8012.68
Calculated EPS (Ann.) (Unit Curr.) 24.0445.7651.1950.70
Calculated EPS (Adj) (Ann.) (Unit Curr.) 24.0445.7651.1950.70
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
Equity 16.0615.6715.6615.61
Reserve & Surplus 0.000.000.000.00
Face Value 1.001.001.001.00
     
Public Shareholding (No Of.Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 21.2828.9030.5729.52
PBDTM(%) 21.1228.7430.4729.46
PATM(%) 11.5418.0919.6019.03